Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
280 studies found for:    "Brain tumor adult"
Show Display Options
Rank Status Study
1 Terminated
Has Results
Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Condition: Adult Brain Tumors
Intervention: Drug: erlotinib hydrochloride
2 Completed Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme
Condition: Recurrent Adult Brain Tumor
Intervention: Drug: Gliadel wafers in combination with O6-benzylguanine
3 Recruiting Light Sedation or Intubated General Anesthesia in Patients With Brain Cancer Undergoing Craniotomy
Condition: Adult Brain Tumor
Interventions: Procedure: Arm I (light sedation);   Procedure: Arm II (intubated general anesthesia);   Other: Arm II (intubated general anesthesia);   Other: Arm I (light sedation)
4 Unknown  Prevalence of Post-craniotomy Headache in Siriraj Hospital
Conditions: Adult Brain Tumor;   Headache
Intervention:
5 Recruiting NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse
Conditions: Adult Brain Glioblastoma;   Recurrent Adult Brain Neoplasm
Interventions: Procedure: Electric Field Therapy;   Biological: Bevacizumab;   Drug: Carmustine;   Other: Quality-of-Life Assessment
6 Completed Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer
Conditions: Brain and Central Nervous System Tumors;   Cognitive/Functional Effects;   Fatigue
Intervention: Drug: modafinil
7 Recruiting Longitudinal Metabolomic and Epigenetic Profiling of Bodyfluids From Patients With Lung and Brain Cancer Receiving Radiation Therapy
Conditions: Adult Brain Tumor;   Lung Cancer;   Radiation Toxicity
Intervention: Other: laboratory biomarker analysis
8 Completed
Has Results
Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients
Conditions: Recurrent Glioblastoma Multiforme;   Malignant Glioma;   Adult Brain Tumor
Interventions: Drug: Vorinostat;   Drug: Bevacizumab
9 Recruiting Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
Conditions: Recurrent Glioblastoma;   Recurrent Adult Brain Tumor;   Gliosarcoma
Interventions: Biological: HSPPC-96;   Drug: bevacizumab
10 Recruiting Carboplatin in Treating Patients With Recurrent High-Grade Gliomas
Conditions: Adult Anaplastic Astrocytoma;   Adult Anaplastic Oligodendroglioma;   Recurrent Adult Brain Tumor
Interventions: Drug: carboplatin;   Procedure: Surgery
11 Completed
Has Results
Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma
Conditions: Adult Glioblastoma;   Depression;   Recurrent Adult Brain Tumor
Interventions: Drug: vorinostat;   Drug: temozolomide;   Procedure: magnetic resonance spectroscopic imaging;   Other: survey administration
12 Completed
Has Results
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
Conditions: Adult Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Interventions: Drug: irinotecan hydrochloride;   Biological: bevacizumab;   Drug: temozolomide
13 Recruiting Sorafenib Tosylate, Valproic Acid, and Sildenafil Citrate in Treating Patients With Recurrent High-Grade Glioma
Conditions: Glioblastoma;   Glioma;   Recurrent Adult Brain Neoplasm
Interventions: Drug: sorafenib tosylate;   Drug: valproic acid;   Drug: sildenafil citrate
14 Enrolling by invitation Risk Factors for Adult-Onset Brain Tumors
Conditions: Brain Neoplasm, Primary;   Brain Neoplasms, Malignant;   Brain Neoplasms, Benign
Intervention:
15 Completed Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors
Conditions: Bone Marrow Suppression;   Brain and Central Nervous System Tumors;   Drug/Agent Toxicity by Tissue/Organ
Interventions: Procedure: filgrastim;   Biological: gene therapy;   Drug: lomustine;   Drug: procarbazine hydrochloride;   Drug: vincristine sulfate;   Procedure: in vitro-treated peripheral blood stem cell transplantation
16 Recruiting NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Interventions: Biological: Bevacizumab;   Device: NovoTTF-l00A;   Other: Quality of Life Assessment
17 Completed Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma
Conditions: Adult Brain Tumor;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Interventions: Procedure: conventional surgery;   Drug: tandutinib;   Other: pharmacological study;   Other: biopsy
18 Active, not recruiting Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Interventions: Drug: dovitinib;   Other: laboratory biomarker analysis
19 Active, not recruiting Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Interventions: Biological: bevacizumab;   Radiation: intensity-modulated radiation therapy;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: proton beam radiation therapy
20 Terminated Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Recurrent Adult Brain Tumor
Interventions: Drug: aminolevulinic acid;   Procedure: therapeutic conventional surgery

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.